News

SVP Josh Hare reveals how pharmaceutical marketers can leverage programmatic and take advantage of its benefits while remaining privacy compliant in PM360.

Successful deployment of SPO’s many moving parts isn’t up to just DSPs, SSPs, or publishers — it’s also up the brands, agencies, and consultants that act as connective tissue to allow SPO to be deployed successfully based on the unique goals and objectives of each advertiser, writes VP of Programmatic Strategy Alex Perrin.

Marketers need to ensure their platforms are ready for the death of the cookie, and it all starts with knowing what questions to ask, writes VP Adam Paz.

Adelphic VP of Programmatic Strategy Alex Perrin outlines the additional benefits of SPO, including the ability to “run experiments and tests to identify the ‘pipes’ [that] yield lower cost impressions while still delivering scale and performance outcomes.”

To survive and achieve marketing nirvana, marketers must embrace an omnichannel approach that aligns all silos into a harmonious, navigable path. By doing so, brands will create an enhanced identity, increase market share and reduce costs.

Agile and efficient marketing is key in 2020. Brands can garner better results and adapt to evolving buyer behavior by investing in omnichannel approaches, writes SVP Brian Bell.

Not all SPO strategies are inherently set up to actually detect or combat fraud, and that is why, according to Adelphic’s VP of Programmatic Strategy Alex Perrin, publishers need to better balance transparency on the supply side and inventory.

A survey from Adelphic of Americans who stream television content shows a 62 percent rise in the number of streamers planning to do most of their holiday shopping online.

Thanks to TV’s continued dominance, advertisers can still connect with viewers and grow their consumer bases in a pandemic. Marketers who take these strategies to heart will be ready for whatever comes next, writes SVP Josh Hare.